Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

International perspectives on newborn screening.

R J Pollitt1

  • 1Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Rodney.Pollitt@sch.nhs.uk

Journal of Inherited Metabolic Disease
|June 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: What degree of hyperphenylalaninaemia requires treatment?

Journal of inherited metabolic disease·2012
Same author

Newborn blood spot screening: new opportunities, old problems.

Journal of inherited metabolic disease·2009
Same author

Qualitative urinary organic acid analysis: methodological approaches and performance.

Journal of inherited metabolic disease·2008
Same author

Introducing new screens: why are we all doing different things?

Journal of inherited metabolic disease·2007
Same author

Population quantile-quantile plots for monitoring assay performance in newborn screening.

Journal of inherited metabolic disease·2007
Same author

Newborn screening for cystic fibrosis: science, legislation, and human values.

Journal of inherited metabolic disease·2004
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Electrospray tandem mass spectrometry (MS-MS) enhances newborn screening, but national policies vary widely. Greater concordance is needed for effective implementation of broad-spectrum disease detection.

Area of Science:

  • Biochemistry
  • Medical Genetics
  • Public Health Policy

Background:

  • Electrospray tandem mass spectrometry (MS-MS) has significantly expanded the scope of newborn blood-spot screening.
  • The adoption and application of MS-MS technology for detecting various diseases differ across countries.

Purpose of the Study:

  • To examine and compare current national policies for MS-MS based newborn screening in the United Kingdom, Germany, and the United States.
  • To highlight the lack of concordance in policy and the challenges in applying established screening principles.

Main Methods:

  • Comparative analysis of national newborn screening policies and guidelines.
  • Review of current practices in the UK, Germany, and the US regarding MS-MS use for disease detection.

Related Experiment Videos

Main Results:

  • Significant policy divergence exists: UK primarily uses MS-MS for phenylketonuria, Germany has restricted its use, and the US proposes broad screening.
  • There is a lack of a universally accepted framework for applying screening principles (Wilson and Jungner, 1968) to decision-making.

Conclusions:

  • The current lack of policy concordance is concerning for the effective implementation of advanced newborn screening technologies.
  • Alternative approaches are necessary to address the heterogeneity of disorders and the diverse benefits of screening beyond reducing morbidity or mortality.